The decision to prescribe semaglutide GLP-1 is made on an individual basis, often recommended for obese individuals with a BMI of 30 or higher, or those who are overweight (with a BMI of 27 or higher) and have at least one weight-related health condition
Versus GLP-1 agonists GLP-1 agonists like semaglutide and tirzepatide have become popular for metabolic optimization and weight loss
I am very concerned about pathologizing kids bodies and weights, particularly when there are no associated health concerns. Erin Parks, Ph.D., co-founder of the virtual eating disorder service Equip Health, told USA Today she would diagnose someone with an eating disorder if they came to her saying they couldn't eat because they were nauseated all the time, but they were happy about it
(The FDA spokesperson said the agency would typically only feature a pregnancy-related risk more prominently if teratogenic events have been observed in humans that is, when the DNA of a fetus has been altered by a medicine, causing congenital disorders